TRT on TikTok: separating gym-bro hype from clinical evidence

What did @calxshreds actually say?

The creator claims to use DHT-derived steroids including primobolan, masteron, and anavar while maintaining a "perfect head of hair" thanks to a product called "Jencaws Revive." They describe it as a multi-formula topical that "blocks androgens from the scalp" including both DHT and testosterone, locally. They also take dutasteride, but frame it as being primarily for prostate protection rather than hair loss prevention. The overall message is that hair loss on cycle is avoidable if you are "proactive."

The framing here is important. This is a response to a follower question, positioned as personal advice, but it reads as a product endorsement with a side of pharmacology. That combination should always get scrutiny.

Does the science back this up?

Partially, but the creator oversimplifies in ways that could mislead people making real decisions about anabolic use. The androgen receptor pathway in hair follicles is real and well-established, but "blocking all androgens locally" is a much bolder claim than the evidence supports for any topical product.

DHT is the primary driver of androgenetic alopecia. Testosterone itself has a weaker binding affinity for the androgen receptor in scalp follicles than DHT, which is why 5-alpha reductase inhibitors like dutasteride are the pharmacological gold standard here. A 2020 review by Adil and Godwin in the Journal of the American Academy of Dermatology confirmed that finasteride and dutasteride have the strongest evidence base for male pattern hair loss. Topical antiandrogens exist, including topical finasteride and topical minoxidil combinations, but the evidence for proprietary blends that claim to block "all androgens" at the scalp is thin to nonexistent in peer-reviewed literature. The creator presents a commercial product as if it has the same evidentiary weight as a licensed drug. It does not.

What did they get wrong (or right)?

They got the biology directionally right but the product claims wrong. Androgens do drive follicle miniaturization, and local scalp application is a legitimate delivery strategy used in clinical formulations. Dutasteride does inhibit both type I and type II 5-alpha reductase, making it more comprehensive than finasteride for DHT suppression. Credit where it is due.

But several things are wrong or at minimum unverifiable. First, claiming the product blocks "any androgen" at the scalp is not supported by published evidence for any over-the-counter or commercially marketed hair product. Second, the framing of dutasteride as being "for the prostate" while downplaying its well-documented role in hair preservation is misleading, whether intentionally or not. Dutasteride is prescribed off-label for androgenetic alopecia precisely because of its dual-enzyme inhibition, as confirmed by Olszewska and Rudnicka in a 2005 study published in the Journal of Investigative Dermatology. Third, the claim that using multiple androgenic steroids results in "zero thinning" because of one topical product is anecdote, not evidence. Genetic variation in androgen receptor sensitivity means this outcome will not generalize.

What should you actually know?

If you are using anabolic steroids and want to protect your hair, the pharmacology matters more than the product marketing. Dutasteride has legitimate clinical evidence behind it for this purpose. Topical minoxidil also has real evidence. A combination topical finasteride plus minoxidil formulation from a licensed compounding pharmacy or brand-name option is the closest thing to a clinically grounded "local" solution currently available.

No product, topical or otherwise, has demonstrated in controlled trials that it can block all androgenic signaling at the scalp without systemic effects. The scalp is vascular and absorbs compounds. "Local only" is a marketing claim that needs to be verified, not assumed. Anyone using dutasteride should also understand its systemic effects, including potential impacts on libido and sexual function, which a 2011 paper by Andriole et al. in the New England Journal of Medicine noted in the context of prostate cancer prevention trials. This is a drug with real systemic reach, not just a scalp protector. Talk to a prescribing clinician before using it as part of a steroid cycle.

The bottom line on this protocol

The creator is not entirely wrong about the biology, but they are selling certainty the science does not provide. The idea that one topical product can block "all androgens" and prevent hair loss during a cycle of multiple androgenic compounds is not backed by peer-reviewed evidence. Dutasteride is real and works, but framing it as a prostate drug rather than a hair drug misrepresents its primary use in this context. Genetic predisposition is the variable that matters most, and no protocol eliminates that risk entirely.